NCT05846971View on ClinicalTrials.gov

Clinical Utility of Methylation-based Prognostic Assay for Barrett's Esophagus

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 26, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Barrett EsophagusEsophageal Cancer
Interventions
OTHER

Educational materials on validated methylation assay

Educational materials include overall information on the assay including what the test does, how to use the test and report, and performance metrics on the test.

Trial Locations (1)

21215

Capsulomics, Inc., Baltimore

Sponsors

Lead Sponsor

Capsulomics, Inc.
All Listed Sponsors
lead

Capsulomics, Inc.

INDUSTRY